Has your Company or your laboratory developed an innovative alternative form of therapeutic antibody?
Do you have a new revolutionary method to analyze, develop or manufacture therapeutic antibodies?
Has your company or Laboratory established a new way to screen for potential new alternative forms of mAbs?
You have a research project that may interest the industrial sector working in immunotherapy?
Share your innovative products, new technologies and research projects that can contribute to the development of new therapeutic antibodies at the pitch Session “New Antibody Formats and Technology”!
Call for abstracts is now closed.
Abstracts will be reviewed by the AIS2016 scientific committee, and authors will be notified of acceptance on or before 29th April 2016 via e-mail.
Carefully review the abstract submission guidelines and speakers responsibilities before submitting your abstract. You can download the Abstract guidelines in here and access the application form by clicking here.
A limited number of grants will be made available for Auvergne-Rhône-Alpes academic researchers selected to give a pitch presentation related to oncology during the “New Antibody Formats & Technology” session. These grants are provided by the Cancéropôle Lyon Auvergne Rhône-Alpes (CLARA) for registration fees only.